These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9101041)

  • 21. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
    Xiao Y; Bunn CL; Bartold PM
    J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
    Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
    Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of plasminogen activator in rat endometrial stromal cells: the role of prostaglandin E2.
    Zhang X; Shu MA; Ross HE; Kennedy TG
    Biol Reprod; 1996 May; 54(5):1046-51. PubMed ID: 8722625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
    Chapman HA; Stone OL; Vavrin Z
    J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
    Seki T; Miyasu T; Noguchi T; Hamasaki A; Sasaki R; Ozawa Y; Okukita K; Declerck PJ; Ariga T
    J Cell Physiol; 2001 Oct; 189(1):72-8. PubMed ID: 11573206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfur mustard upregulates the expression of interleukin-8 in cultured human keratinocytes.
    Lardot C; Dubois V; Lison D
    Toxicol Lett; 1999 Oct; 110(1-2):29-33. PubMed ID: 10593592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.
    Keski-Oja J; Koli K
    J Invest Dermatol; 1992 Aug; 99(2):193-200. PubMed ID: 1629632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
    Webber MM; Waghray A
    Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urokinase synthesis and binding by glomerular epithelial cells in culture.
    Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
    Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
    Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
    J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
    Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity.
    Dear AE; Medcalf RL
    Biochim Biophys Acta; 2000 Jun; 1492(1):15-22. PubMed ID: 11004477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
    Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H
    Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
    Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
    Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cells.
    Nguyen G; Li XM; Peraldi MN; Zacharias U; Hagège J; Rondeau E; Sraer JD
    Kidney Int; 1994 Jul; 46(1):208-15. PubMed ID: 7933839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
    Ronday HK; Smits HH; Quax PH; van der Pluijm G; Löwik CW; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.